Drug interactions
Arformoterol + Triptorelin
Severity: Minor
Arformoterol and Triptorelin: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Arformoterol, a long-acting beta-agonist, can prolong QTc and lower potassium, and triptorelin may add modest QT prolongation. Together they may increase arrhythmia risk in patients with heart disease.
What this interaction means in plain words
Arformoterol and Triptorelin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Arformoterol belongs to Respiratory; Triptorelin belongs to Endocrine.
Why it happens
Additive QT effects, with beta-agonist-induced hypokalemia.
What to do
Usually no change is required at recommended doses. Check potassium and ECG in patients with known QT prolongation or cardiac disease.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Arformoterol and Triptorelin, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Triptorelin
Other interactions of Arformoterol
Frequently asked questions
Can I take Arformoterol with Triptorelin?
MediHelp rates the interaction as minor. Arformoterol and Triptorelin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Arformoterol, a long-acting beta-agonist, can prolong QTc and lower potassium, and triptorelin may add modest QT prolongation. Together they may increase arrhythmia risk in patients with heart disease.
How serious is the interaction between Arformoterol and Triptorelin?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Usually no change is required at recommended doses. Check potassium and ECG in patients with known QT prolongation or cardiac disease.
What other medicines interact with Triptorelin?
MediHelp also lists interactions of Triptorelin with, for example, Amisulpride, Arsenic trioxide, Bedaquiline. The full list is on the Triptorelin page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
